Salio Gen Therapeutics
Biotechnology, 399 Binney St, Lexington, Massachusetts, 02139, United States, 51-200 Employees
Phone Number: 85********
Who is SALIOGEN THERAPEUTICS
SalioGen is advancing a new category of genetic medicine we call Gene Coding, which works by adding a new genomic code to turn on, off or modify the functions of new or existing genes. We...
Read More
-
Headquarters: 399 Binney St, Lexington, Massachusetts, 02139, United States
-
Date Founded: 2020
-
Employees: 51-200
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8731
Does something look wrong? Fix it. | View contact records from SALIOGEN THERAPEUTICS
SalioGen Therapeutics Org Chart and Mapping
Email
Phone
Similar Companies to SalioGen Therapeutics
Avenge Bio
-
11-50
-
$ 1 Million to 5 Million
Beam Therapeutics
-
501-1000
-
$ 50 Million to 100 Million
Frequency Therapeutics
-
51-200
-
$ 25 Million to 50 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding SalioGen Therapeutics
Answer: SalioGen Therapeutics's headquarters are located at 399 Binney St, Lexington, Massachusetts, 02139, United States
Answer: SalioGen Therapeutics's phone number is 85********
Answer: SalioGen Therapeutics's official website is https://saliogen.com
Answer: SalioGen Therapeutics's revenue is $25 Million to $50 Million
Answer: SalioGen Therapeutics's SIC: 8731
Answer: SalioGen Therapeutics has 51-200 employees
Answer: SalioGen Therapeutics is in Biotechnology
Answer: SalioGen Therapeutics top competitors include: Avenge Bio , Beam Therapeutics , Frequency Therapeutics
Answer: SalioGen Therapeutics contact info: Phone number: 85******** Website: https://saliogen.com
Answer: SalioGen is advancing a new category of genetic medicine we call Gene Coding, which works by adding a new genomic code to turn on, off or modify the functions of new or existing genes. We are advancing potentially curative therapies, with an initial focus on developing durable, safe and accessible genetic medicine to more patients with inherited disorders. At SalioGen, we are driven not only by our efforts to realize the immense potential of our science, but also by our dedication and commitment to developing medicines that can make a significant impact on patients lives. Our Gene Coding approach is guided by our Exact DNA Integration Technology (EDIT) platform, a genome engineering technology that leverages proprietary mammal-derived enzymes we call Saliogase. With broad applicability, non-viral delivery capabilities of any size gene and significant manufacturing advantages, EDIT has the potential to transform the treatment paradigm for inherited disorders and beyond. Looking ahead, SalioGen plans to explore Gene Codings capabilities to streamline cell therapy, cell engineering, and biologics manufacturing with the goal of helping an even broader population of patients in need.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month